Una candidatura completa en un minuto
Currículum y carta de presentación personalizados, listos para enviar.
Amsterdam UMC invites applications for a Doctoral Candidate (DC2) to work on Work Package 2 within the MERIT project, focusing on implementation science for biosafety practices in high-risk pathogen research. You will map determinants of safety compliance through literature reviews, interviews, and surveys across multiple EU institutions.
You will collaborate with laboratory staff, doctoral candidates and supervisors to tailor strategies, piloting them in real-world settings to improve
Organisation/Company Amsterdam UMC Research Field Medical sciences » Medicine Researcher Profile First Stage Researcher (R1) Application Deadline 30 Oct 2026 - 22:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
MERIT (MEtabolic Reprogramming in viral pathogenesis: from Infection to Therapeutic innovations) is an EU-funded MSCA training programme aimed at better understanding how viruses affect the human body. Coordinated by Dr. Adithya Sridhar, Assistant Professor, and Prof. Dr. Dasja Pajkrt, Professor of Pediatric Infectious diseases, from the OrganoVIR Labs at Amsterdam UMC (location AMC), this project brings together 7 academic institutions and 12 associated partners from across Europe.
Within MERIT, researchers will take a new, holistic approach that focuses on infections and host metabolism to unravel virus-induced metabolic reprogramming and its impact on human health. The project’s objective lies in understanding the complex interplay between viruses and host cells, focusing on metabolic reprogramming, and long-term consequences of infection. This will be achieved by combining three methodological pillars: human organoids, integrative and spatial omics, and advanced microscopy.
The project aims to bridge the gap between biosafety guidelines and everyday laboratory practice by strengthening the implementation of safety measures. Using an implementation science approach, the project will systematically identify behavioural, social, and organisational determinants of compliance, and translate these into tailored, context-sensitive implementation strategies.
Through qualitative and mixed methods research (e.g. literature reviews, interviews, questionnaires including discrete choice experiments or vignettes, and observations) the project will map the key drivers and barriers of safety behaviour. Building on these insights, it will explore how these determinants shape the mechanisms through which implementation strategies work, and under which conditions they are most effective and sustainable.
In close collaboration with laboratory staff, including doctoral candidates and supervisors, suitable implementation strategies will be selected and tailored to local workflows, resources, and safety culture, and subsequently piloted in real-world laboratory settings. Ultimately, the project aims to enhance biosafety, research quality, and public trust in high-risk pathogen research.
At the Amsterdam UMC in the Netherlands, MERIT is looking for a Doctoral Candidate (DC) to work on Work Package 2. As DC2, your objectives are:
You will be guided during your research project by Dr. Rosa van Mansfeld, Dr. Mireille Dekker and Dr. Adithya Sridhar. You can apply for this position until 30 October 2026. Applications submitted after this date will not be considered.
Amsterdam UMC, location AMC, houses the university hospital and the medical faculty of the University of Amsterdam, as well as several research institutes.
The research group Implementation of Infection Prevention (IIP) is embedded within the Department of Medical Microbiology and Infection Prevention (MMI) and is affiliated with OrganoVIR Labs. The research group IIP collaborates with the Amsterdam Immunity and Infection Institute,the Amsterdam Public Health research institute, and other (inter)national researchers.
From various perspectives, we focus on improving infection prevention in healthcare. Our scientific research integrates knowledge and insights from fields such as implementation science and behavioural science.
The OrganoVIR Labs is uniquely embedded within both the Department of Medical Microbiology and Infection Prevention (MMI) and the Department of Pediatrics and is affiliated with the Amsterdam Immunity and Infection Institute (AIII), Amsterdam Reproduction and Development (AR&D), and Emma Centre for Personalized Medicine (Emma CPM). This multidisciplinary positioning fosters close collaboration between fundamental, translational, and clinical research.